Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1969;39:I-155-I-161

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RODGERS, B. M.
Right arrow Articles by SABISTON, D. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by RODGERS, B. M.
Right arrow Articles by SABISTON, D. C., JR.

(Circulation. 1969;39:I-155.)
© 1969 American Heart Association, Inc.


Hemolytic Anemia Following Prosthetic Valve Replacement

BRADLEY M. RODGERS M.D.1 DAVID C. SABISTON JR. M.D.1

1 From the Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Ten patients with marked hemolytic anemia secondary to prosthetic cardiac valve replacement are presented. Although the etiology of this disorder is not understood, available evidence supports the concept of blood destruction secondary to turbulence around valves as the primary factor. These studies illustrate the technical difficulties associated with reoperation and the disappointing results which often follow. Emphasis is placed on the role of iron replacement and folic acid therapy in association with moderate reduction in exercise. This regimen has produced gratifying results in the management of these patients.